KYORIN Pharmaceutical Co., Ltd.
Researches, develops, and sells a portfolio of ethical, generic, and OTC medicines.
4569 | T
Overview
Corporate Details
- ISIN(s):
- JP3247090008
- LEI:
- Country:
- Japan
- Address:
- 千代田区大手町一丁目３番７号
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
KYORIN Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacturing, and commercialization of medicines. The company's business focuses on several key areas, including the creation of innovative new ethical drugs through its own drug discovery and in-licensing activities. Its portfolio also encompasses generic drugs and over-the-counter (OTC) products, such as the COOL ONE series. The company aims to contribute to public health by developing high-value treatments that meet medical needs. In April 2023, the current entity was formed when KYORIN Holdings, Inc. merged with its wholly-owned subsidiary, KYORIN Pharmaceutical Co., Ltd., and adopted the subsidiary's name.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 07:42 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2025-11-13 07:36 |
Interim Report
半期報告書－第68期(2025/04/01－2025/09/30)
|
Japanese | 220.9 KB | ||
| 2025-06-26 07:25 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.5 KB | ||
| 2025-06-19 08:55 |
Governance Information
内部統制報告書－第67期(2024/04/01－2025/03/31)
|
Japanese | 27.1 KB | ||
| 2025-06-19 08:53 |
Registration Form
確認書
|
Japanese | 8.9 KB | ||
| 2025-06-19 08:50 |
Registration Form
有価証券報告書－第67期(2024/04/01－2025/03/31)
|
Japanese | 1.4 MB | ||
| 2024-11-13 07:27 |
Interim Report
確認書
|
Japanese | 8.9 KB | ||
| 2024-11-13 07:24 |
Interim Report
半期報告書－第67期(2024/04/01－2025/03/31)
|
Japanese | 216.2 KB | ||
| 2024-06-28 08:30 |
Post-Annual General Meeting Information
臨時報告書
|
Japanese | 23.5 KB | ||
| 2024-06-24 08:53 |
Governance Information
内部統制報告書－第66期(2023/04/01－2024/03/31)
|
Japanese | 24.3 KB | ||
| 2024-06-24 08:51 |
Registration Form
確認書
|
Japanese | 8.9 KB | ||
| 2024-06-24 08:47 |
Registration Form
有価証券報告書－第66期(2023/04/01－2024/03/31)
|
Japanese | 1.3 MB | ||
| 2024-02-14 07:07 |
Quarterly Report
確認書
|
Japanese | 8.9 KB | ||
| 2024-02-14 07:05 |
Quarterly Report
四半期報告書－第66期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 190.9 KB | ||
| 2023-11-14 07:36 |
Report Publication Announcement
確認書
|
Japanese | 8.2 KB |
Automate Your Workflow. Get a real-time feed of all KYORIN Pharmaceutical Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KYORIN Pharmaceutical Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KYORIN Pharmaceutical Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
